A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy.
Smaradottir
Agnes
A
University of Connecticut Health Center, USA. smaradottir@gme.vchc.edu
Bona
Robert
R
D016063:Blood Loss, Surgical / Q000517:prevention & control; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013965:Thyroidectomy / Q000009:adverse effects*; D016896:Treatment Outcome; D014842:von Willebrand Diseases / Q000188:drug therapy*
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa